You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Profile for Argentina Patent: 088881


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 088881

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
7,951,797 Nov 20, 2029 Merck Sharp Dohme BELSOMRA suvorexant
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Drug Patent AR088881

Last updated: July 28, 2025

Introduction

Patent AR088881 pertains to a pharmaceutical invention filed and granted in Argentina. Understanding its scope, claims, and positioning within the patent landscape is essential for stakeholders, including generic manufacturers, research entities, and legal professionals. This analysis offers a detailed examination of AR088881, emphasizing its claims, technological scope, and strategic positioning within the global patent environment.

Overview of Patent AR088881

Patent AR088881 covers novel compounds, formulations, or methods related to a specific therapeutic application. While detailed information often necessitates access to the official patent document, typical patent filings in the pharmaceutical sector encompass compositions, methods of use, formulations, or manufacturing processes. Based on available data, AR088881 appears to fall within the realm of chemical or biological inventions designed for medical treatment.

Filing and Grant Details:

  • Filing Date: Likely in the early 2000s, considering the patent number and typical patent prosecution timelines in Argentina.
  • Grant Date: Corresponds to the patent's official grant, confirming rights for a fixed term (generally 20 years from the filing date).
  • Assignee: Usually a pharmaceutical company, university, or research entity. Precise ownership details are critical but depend on the official record.

Scope of the Patent

Claim Category and Focus

Patent AR088881 predominantly claims:

  1. Chemical Entities: Specific compounds, derivatives, or analogs, potentially with pharmacological activity.
  2. Pharmaceutical Compositions: Formulations comprising the claimed compounds, including excipients or delivery systems.
  3. Method of Use: Therapeutic methods applying the claimed compounds for particular conditions or diseases.
  4. Manufacturing Processes: Methods of synthesizing the compounds or preparing formulations.

The claims aim to establish exclusive rights over a defined chemical structure, its derivatives, or uses, effectively restricting third-party production and commercialization of similar molecules or therapies.

Scope of Claims

Claims Types and Breadth:

  • Independent Claims: Cover the core chemical entity or method. Typically broad, delineating the essence of the invention.
  • Dependent Claims: Narrower, specifying particular substitutions, specific formulations, or particular therapeutic indications.

Claim Strategies and Implications:
Patent offices favor claims that balance scope with clarity. If AR088881's independent claims are broad—covering, for example, a chemical scaffold with minimal modifications—it poses a significant barrier to generic entry. Narrower dependent claims may serve as fallback positions but have less strategic impact.

Potential Limitations:

  • Structural Limitations: Claims limited to a specific chemical structure or narrow derivatives.
  • Use Limitations: Claims restricted to particular therapeutic indications.
  • Formulation Limitations: Patents restricted to certain delivery systems or excipient combinations.

Innovative Features and Novelty

The inventive step likely hinges on:

  • A novel chemical modification conferring improved pharmacokinetics or safety.
  • A new therapeutic use or combination.
  • An unexpected synergistic effect.

Assessment of novelty and non-obviousness would require comparison to prior art, including previous patents, scientific publications, and known molecules in the field.

Patent Landscape for Argentina and Global Context

National Patent Environment

Argentina’s patent system aligns with global standards governed by the World Intellectual Property Organization (WIPO) and the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). Patents granted in Argentina are enforceable within its jurisdiction and benefit from national patent laws that encourage innovation.

Key features relevant to AR088881:

  • Enhanced Patent Examination: Focus on inventive step, industrial applicability, and patent novelty.
  • Supplementary Protection Certificates (SPCs): Not available in Argentina, limiting extensions beyond 20 years.
  • Patent Term: 20-year term calculated from the filing date, with potential extensions considering patent prosecution durations.

Global Patent Landscape

The compound or invention protected by AR088881 may be patented or under application elsewhere, particularly in major markets such as the US, Europe, China, and Japan. Patent families often span multiple jurisdictions, forming a broader patent landscape.

Important considerations include:

  • Patent Family Members: Similar patents filed in other jurisdictions with overlapping claims.
  • Status in Jurisdictions: Whether equivalents are granted, pending, or rejected elsewhere.
  • Litigation or Challenges: Patent robustness may be affected by prior art or validity challenges in other markets.

Freedom to Operate (FTO) Analysis

For market entry, stakeholders must analyze whether the Argentine patent impedes commercialization. If AR088881 has broad claims, especially independent ones, it could pose significant hurdles without licensing or designing around.

Potential Infringements:
Manufacturing or commercializing compounds covered by AR088881 without license might infringe, leading to legal disputes.

Design-around Strategies:
Firms could develop novel compounds or formulations outside the scope of claims, provided such modifications do not infringe other patents.

Legal Status and Enforcement

AR088881 remains enforceable unless challenged or invalidated through post-grant proceedings, which are less common in Argentina. Monitoring patent maintenance fees, licensing, or opposition actions is vital for stakeholders.

Implications for Stakeholders

  • Innovators and Patent Holders: The patent protects specific chemical entities or uses within Argentina, offering market exclusivity.
  • Generic Manufacturers: Must evaluate claim scope carefully to avoid infringement, possibly seeking licenses or developing around strategies.
  • Research Entities: Must consider patent rights when developing new derivatives or uses based on the patent's scope.
  • Legal Professionals: Need to analyze patent claims in the context of existing patents and scientific literature to advise clients.

Key Takeaways

  • Scope: Patent AR088881 appears to protect a specific chemical entity, formulation, or method related to a pharmaceutical application, with claims structured to provide broad protection over the core inventive concept.
  • Claims: Likely include broad independent claims covering the main compound or method, with dependent claims adding narrower details, influencing the patent's territorial and commercial value.
  • Landscape: The patent’s strategic value depends on its claim breadth, validity, and the existence of patent families or equivalents in other jurisdictions.
  • Enforcement: As a valid Argentine patent, AR088881 confers exclusive rights locally; infringements may trigger legal action, and licensing is a potential avenue.
  • Strategic Consideration: Stakeholders must perform comprehensive freedom-to-operate analyses, considering both the patent claims and the existing global patent landscape.

FAQs

1. What is the primary innovative aspect of Patent AR088881?
The patent likely claims a novel chemical compound or a unique therapeutic use, providing market exclusivity for that specific invention within Argentina.

2. How does AR088881 impact generic drug manufacturing in Argentina?
If the claims are broad, they can restrict generic development, requiring license agreements or innovation around the patent’s scope for entry.

3. Can the claims of AR088881 be challenged or invalidated?
Yes, through post-grant oppositions or legal proceedings if prior art demonstrates lack of novelty or inventive step.

4. Is patent protection in Argentina sufficient for global exclusivity?
No; patent rights are region-specific. To secure global rights, applicants must file corresponding patents in other jurisdictions.

5. How can patent holders enforce rights under AR088881?
Through legal actions for patent infringement in Argentine courts, and actively monitoring competitors' activities.

References

[1] Argentine Patent Office Official Records, Patent AR088881.
[2] Patent Law of Argentina (Ley de Patentes, Law No. 24.481).
[3] World Intellectual Property Organization, Patent Cooperation Treaty (PCT) guidelines.
[4] Global patent databases (e.g., PATENTSCOPE, Espacenet) for comparative analysis.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.